Structure and substrate specificity of the Pim-1 kinase

被引:168
作者
Bullock, AN
Debreczeni, J
Amos, AL
Knapp, S
Turk, BE
机构
[1] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[2] Univ Oxford, Ctr Struct Genom, Botnar Res Ctr, Oxford OX3 7LD, England
基金
英国惠康基金;
关键词
D O I
10.1074/jbc.M510711200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Pim kinases are a family of three vertebrate protein serine/threonine kinases (Pim-1, -2, and -3) belonging to the CAMK (calmodulin-dependent protein kinase-related) group. Pim kinases are emerging as important mediators of cytokine signaling pathways in hematopoietic cells, and they contribute to the progression of certain leukemias and solid tumors. A number of cytoplasmic and nuclear proteins are phosphorylated by Pim kinases and may act as their effectors in normal physiology and in disease. Recent crystallographic studies of Pim-1 have identified unique structural features but have not provided insight into how the kinase recognizes its target substrates. Here, we have conducted peptide library screens to exhaustively determine the sequence specificity of active site-mediated phosphorylation by Pim-1 and Pim-3. We have identified the major site of Pim-1 autophosphorylation and find surprisingly that it maps to a novel site that diverges from its consensus phosphorylation motif. We have solved the crystal structure of Pim-1 bound to a high affinity peptide substrate in complexes with either the ATP analog AMP-PNP or the bisindolylmaleimide kinase inhibitor 2-[1-(3-dimethylaminopropyl)-1H-indol-3- yl]-3-(1H-indol3-yl) maleimide HCl. These structures reveal an unanticipated mode of recognition for basic residues upstream of the phosphorylation site, distinct from that of other kinases with similar substrate specificity. The structures provide a rationale for the unusually high affinity of Pim kinases for peptide substrates and suggest a general mode for substrate binding to members of the CAMK group.
引用
收藏
页码:41675 / 41682
页数:8
相关论文
共 65 条
[21]   The Pim kinases control rapamycin-resistant T cell survival and activation [J].
Fox, CJ ;
Hammerman, PS ;
Thompson, CB .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (02) :259-266
[22]   The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor [J].
Fox, CJ ;
Hammerman, PS ;
Cinalli, RM ;
Master, SR ;
Chodosh, LA ;
Thompson, CB .
GENES & DEVELOPMENT, 2003, 17 (15) :1841-1854
[23]   CHARACTERIZATION OF THE PROTOONCOGENE PIM-1 - KINASE-ACTIVITY AND SUBSTRATE RECOGNITION SEQUENCE [J].
FRIEDMANN, M ;
NISSEN, MS ;
HOOVER, DS ;
REEVES, R ;
MAGNUSON, NS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 298 (02) :594-601
[24]   Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines [J].
Fujii, C ;
Nakamoto, Y ;
Lu, PR ;
Tsuneyama, K ;
Popivanova, BK ;
Kaneko, S ;
Mukaida, N .
INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (02) :209-218
[25]   Kinase peptide specificity: Improved determination and relevance to protein phosphorylation [J].
Fujii, K ;
Zhu, GZ ;
Liu, Y ;
Hallam, J ;
Chen, L ;
Herrero, J ;
Shaw, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (38) :13744-13749
[26]   A Pim kinase inhibitor, please [J].
Giles, F .
BLOOD, 2005, 105 (11) :4158-4159
[27]   Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival [J].
Hammerman, PS ;
Fox, CJ ;
Birnbaum, MJ ;
Thompson, CB .
BLOOD, 2005, 105 (11) :4477-4483
[28]   Lymphocyte transformation by Pim-2 is dependent on nuclear factor-κB activation [J].
Hammerman, PS ;
Fox, CJ ;
Cinalli, RM ;
Xu, A ;
Wagner, JD ;
Lindsten, T ;
Thompson, CB .
CANCER RESEARCH, 2004, 64 (22) :8341-8348
[29]   A rapid method for determining protein kinase phosphorylation specificity [J].
Hutti, JE ;
Jarrell, ET ;
Chang, JD ;
Abbott, DW ;
Storz, P ;
Toker, A ;
Cantley, LC ;
Turk, BE .
NATURE METHODS, 2004, 1 (01) :27-29
[30]   Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002 [J].
Jacobs, MD ;
Black, J ;
Futer, O ;
Swenson, L ;
Hare, B ;
Fleming, M ;
Saxena, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (14) :13728-13734